192 related articles for article (PubMed ID: 23027454)
21. Inherited cardiac arrhythmia syndromes: what have they taught us about arrhythmias and anti-arrhythmic therapy?
Subbiah RN; Campbell TJ; Vandenberg JI
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):906-12. PubMed ID: 15659058
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacotherapy of cardiac arrhythmias in women--what do we know, do we have a choice?].
Klocek M; Skrzek A; Czarnecka D
Przegl Lek; 2014; 71(3):155-9. PubMed ID: 25154213
[TBL] [Abstract][Full Text] [Related]
23. Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem?
Antzelevitch C
J Electrocardiol; 2004; 37 Suppl():15-24. PubMed ID: 15534788
[TBL] [Abstract][Full Text] [Related]
24. A practical approach to torsade de pointes.
Roden DM
Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
[TBL] [Abstract][Full Text] [Related]
25. Long QT: good, bad or indifferent?
Surawicz B; Knoebel SB
J Am Coll Cardiol; 1984 Aug; 4(2):398-413. PubMed ID: 6145737
[TBL] [Abstract][Full Text] [Related]
26. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
Turker I; Ai T; Itoh H; Horie M
Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
[TBL] [Abstract][Full Text] [Related]
28. Quinidine-A legacy within the modern era of antiarrhythmic therapy.
Vitali Serdoz L; Rittger H; Furlanello F; Bastian D
Pharmacol Res; 2019 Jun; 144():257-263. PubMed ID: 31026503
[TBL] [Abstract][Full Text] [Related]
29. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
Steinbeck G
Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
[TBL] [Abstract][Full Text] [Related]
30. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit.
Beitland S; Platou ES; Sunde K
Acta Anaesthesiol Scand; 2014 Mar; 58(3):266-72. PubMed ID: 24397608
[TBL] [Abstract][Full Text] [Related]
32. Optimal management with Class I and Class III antiarrhythmic drugs should be done in the outpatient setting: protagonist.
Thibault B; Nattel S
J Cardiovasc Electrophysiol; 1999 Mar; 10(3):472-81. PubMed ID: 10210515
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological approach to the treatment of long and short QT syndromes.
Patel C; Antzelevitch C
Pharmacol Ther; 2008 Apr; 118(1):138-51. PubMed ID: 18378319
[TBL] [Abstract][Full Text] [Related]
34. Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks.
Sharifi M; Buzatu D; Harris S; Wilkes J
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):497. PubMed ID: 29297274
[TBL] [Abstract][Full Text] [Related]
35. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
36. [Arrhythmogenic effects of anti-arrhythmia agents].
Pfeiffer D; Rostock KJ; Rathgen K; Schirdewan A; Kleiner HJ
Z Gesamte Inn Med; 1987 Jul; 42(14):390-4. PubMed ID: 3673134
[TBL] [Abstract][Full Text] [Related]
37. Proarrhythmia, a serious complication of antiarrhythmic drugs.
Podrid PJ
Curr Cardiol Rep; 1999 Nov; 1(4):289-96. PubMed ID: 10980856
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms.
Tadros R; Ton AT; Fiset C; Nattel S
Can J Cardiol; 2014 Jul; 30(7):783-92. PubMed ID: 24970790
[TBL] [Abstract][Full Text] [Related]
39. Long QT syndromes and torsade de pointes.
Viskin S
Lancet; 1999 Nov; 354(9190):1625-33. PubMed ID: 10560690
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced torsade de pointes. Incidence, management and prevention.
Faber TS; Zehender M; Just H
Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
